Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
Researchers at University of Michigan publish new data on breast cancer
December 18th, 2007
According to recent research from the United States, "Beginning in the late 1980s, many health insurers refused to cover highdose chemotherapy with autologous bone marrow transplant (HDC/ABMT) for highrisk and metastatic breast cancer patients. Insurers denied coverage because there was no persuasive evidence of clinical effectiveness." "In response, many women sued to compel coverage. After years of litigation and the expenditure of approximately $ 3 billion, randomized clinical trials ( RCTs) showed that the procedure was no more effective and possibly more harmful than conventional therapy. To understand whether and how litigation contributed to the diffusion of the...
Source: Cancer Weekly (2007-12-18)
|
